Sharemaestro Newsreel

Fulgent Genetics, Inc. $FLGT Shares Purchased by Quantinno Capital Management LP

Quantinno Capital Management LP significantly increased its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) by 374.7% in the first quarter, bringing its total holdings to 137,479 shares valued at $2.19 million. Institutional investors now own 48.06% of FLGT, while company insiders hold 36.18%, with recent …

Exagen at Canaccord Genuity growth conference: turnaround gains pace

Exagen (XGN) showcased its business turnaround at Canaccord Genuity’s 46th Annual Growth Conference, detailing its shift from significant cash burn to near breakeven while expanding its autoimmune testing franchise. The company reported a 57% increase in average selling price to $446, 21% year-over-year revenue …

NewEdge Advisors LLC Increases Stock Holdings in IQVIA Holdings Inc. $IQV

NewEdge Advisors LLC increased its stake in IQVIA Holdings Inc. by 21.5% in the first quarter, now holding shares valued at approximately $6.03 million. This increase comes as IQVIA reported strong quarterly earnings, surpassing analyst expectations with adjusted EPS of $3.15 and revenue of …

Adaptive Biotechnologies stock hits 52-week high at 25.04 USD By Investing.com

Adaptive Biotechnologies (ADPT) stock has reached a 52-week high of $25.04, reflecting a 104% increase over the past year and underscoring strong performance in the biotechnology sector. The company's market capitalization is now $3.95 billion, with 50% revenue growth, indicating strong investor confidence. This …

Non-Viral Transfection Reagents Market Report (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User & Region, Featuring Bio-Rad, MaxCyte, MilliporeSigma, Thermo Fisher Scientific

Company Logo Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The "Non-Viral Transfection Reagents Market (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User and Geographical Regions-Trends and Forecast Till 2035" has been added to ResearchAndMarkets.com's offering. The global non-viral transfection reagents market …

E. Ohman J or Asset Management AB Increases Stock Position in RadNet, Inc. $RDNT

E. Ohman J or Asset Management AB significantly increased its stake in RadNet, Inc. by 1,144.3% in the second quarter, now owning 452,966 shares worth $27.9 million. This move comes as RadNet reported strong Q2 results with a 25% revenue increase and adjusted EPS …

Danaher Corporation $DHR Stock Position Lessened by Defender Capital LLC.

RadNet, Inc. Revenue Breakdown – FWB:PQIA

RadNet, Inc. generated 1.74 billion EUR in revenue last year, with its Imaging Center segment contributing the most at 1.69 billion EUR. The United States was the primary revenue source, accounting for 1.71 billion EUR. This information highlights the company's key revenue streams and …

Biotech Stocks At 52-Week Highs - SLN +29% & ABCL +34% On Positive Trial Data, CPIX, CLDX, BDSX

(RTTNews) - The following biotech stocks reached a 52-week high on August 10, 2026, driven by key catalysts such as positive quarterly reports or the release of promising results from clinical trials. Silence Therapeutics plc (SLN) Silence Therapeutics is a biotechnology company engaged in …

Stock futures edge lower as traders focus on Strait of Hormuz reopening

[The New York Stock Exchange on the Wall street sign] Dmitry Vinogradov Stock index futures were lower on Tuesday as traders continued to focus on developments related to the reopening of the Strait of Hormuz. Dow futures (INDU [https://seekingalpha.com/symbol/INDU]) -0.17%, S&P 500 futures (SPX …

Personalis, Inc. $PSNL Stock Holdings Lifted by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP increased its holdings in Personalis, Inc. (PSNL) by 8.4% in the first quarter, now owning 1.07 million shares valued at approximately $6.8 million. Despite this, insiders have sold a significant amount of stock, and the company has a consensus "Hold" …

Bank of America Corp DE Has $60.14 Million Stock Holdings in Icon Plc $ICLR

Bank of America Corp DE reduced its stake in Icon Plc (NASDAQ:ICLR) by 10.9% in the first quarter, now holding 543,487 shares valued at approximately $60.14 million. Despite the reduction by BofA, institutional investors and hedge funds collectively own 95.61% of Icon's stock. The …

Twist Bioscience (NASDAQ:TWST) Reaches New 1-Year High - Here's What Happened

Twist Bioscience (NASDAQ:TWST) reached a new 52-week high, trading as high as $121.50, despite its average analyst price target being below current trading levels. The company reported higher-than-expected revenue but a wider adjusted loss per share. While institutional investors have increased their holdings, company …

Assenagon Asset Management S.A. Sells 90,551 Shares of Medpace Holdings, Inc. $MEDP

Assenagon Asset Management S.A. significantly reduced its stake in Medpace Holdings, Inc. by selling 90,551 shares, leaving it with 25,772 shares valued at $13.65 million. Despite this, Medpace exceeded Q2 earnings expectations with $4.25 EPS and $707.33 million in revenue, and issued strong fiscal …

IMDX Looks 284.7% Overvalued on GF Value™

Insight Molecular Diagnostics Inc (IMDX) is considered 284.7% overvalued based on its GF Value™ despite optimism around future FDA authorization for its GraftAssureDx test and expanded Medicare reimbursement. The company reported a Q2 adjusted EBITDA loss and an upward revision of its cash burn …

RadNet Q2 Earnings Call Highlights

RadNet (RDNT) reported record Q2 2026 revenue of $622.7 million and adjusted EBITDA of $99.7 million, driven by increased advanced imaging volumes, strategic acquisitions, and growth in its Digital Health segment. The company also announced FDA 510(k) clearance for its DeepHealth breast ultrasound AI …

Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of "Moderate Buy" by Brokerages

Charles River Laboratories International (NYSE:CRL) has received an average "Moderate Buy" rating from sixteen brokerages, with an average 12-month price target of $255.65. This follows the company exceeding quarterly earnings expectations with an adjusted EPS of $3.02 and revenue of $1.0 billion. Despite recent …

Revvity (RVTY) Lifted Its Outlook, Is The Stock Fully Priced?

Revvity (RVTY) recently released its Q2 2026 results and declared a dividend, leading to a lifted outlook. The stock has seen positive short-term momentum, but its valuation is split, with a fair value estimate suggesting it's undervalued at $121.07, while its P/E ratio of …

Insight Molecular Diagnostics signals ~$8M quarterly cash burn in H2 2026 while targeting FDA authorization later this year

Earnings Call Insights: Insight Molecular Diagnostics (IMDX) Q2 2026 MANAGEMENT VIEW * "It feels great to be coming to you today with line of sight on expected FDA marketing authorization for GraftAssureDx" (President, CEO & Director Joshua Riggs), adding, "We continue to target receipt …

Should You Worry That a Natera Co-Founder Sold Shares? Here's What Long-Term Investors Should Know

Natera co-founder Matthew Rabinowitz sold 731 shares to cover tax obligations from vested restricted stock units, an action dictated by a pre-established plan rather than a discretionary investment decision. This sale represents a negligible fraction of his substantial holdings, valued at over $616 million. …

METTLER-TOLEDO INTERNATIONAL INC. : MORGAN STANLEY RAISES TARGET PRICE TO $1450 FROM $1275

Morgan Stanley has increased its target price for METTLER-TOLEDO INTERNATIONAL INC. (MTD) shares to $1450 from the previous $1275. This update reflects the investment bank's revised outlook on the company's stock.

RadNet, Inc. (RDNT) Investor Outlook: Capitalizing on a 23.99% Potential Upside in the Booming Diagnostics Sector

RadNet, Inc. (RDNT) is positioned as a significant player in the diagnostics sector with a market capitalization of $5.69 billion. Analysts project a 23.99% potential upside, driven by strong revenue growth (22.10%) and strategic investments in AI and DeepHealth OS. While the company shows …

Waters Corporation (NYSE:WAT) Given Average Recommendation of "Moderate Buy" by Analysts

Waters Corporation (NYSE:WAT) has received a "Moderate Buy" consensus rating from twenty analysts, with an average 12-month price target of $418.10. The company recently surpassed quarterly earnings and revenue expectations, reporting $3.05 in adjusted EPS and $1.65 billion in revenue. Shares are currently trading …

Does OPKO Health’s Sharply Narrowed Q2 Loss Reset the Bull Case for OPKO Health (OPK)?

OPKO Health, Inc. (OPK) reported a significantly narrowed net loss of US$8.42 million in Q2 2026, alongside increased revenue of US$163.58 million, which could signal progress in cost control and operations management. While the company remains unprofitable, this positive development, combined with their 2026 …

Personalis (PSNL) Reports Higher Sales And Wider Losses, Does The Stock Look Fully Valued?

Personalis (PSNL) recently reported Q2 2026 results with increased sales but wider losses, leading to a reassessment of its stock by investors. Despite strong recent share price performance, the stock is currently trading slightly above analyst targets, with a narrative fair value suggesting it …

What Investors Should Know About a Mettler-Toledo Director's Two Transactions This Past Week

A director at Mettler-Toledo International Inc. (MTD), Thomas P. Salice, recently sold 417 shares of the company, valued at approximately $600,651. This transaction was an exercise-and-sell of options, not a change in his long-term investment strategy, as he maintained significant indirect holdings. Mettler-Toledo has …

A Mettler-Toledo Director Sold $600,000 in Stock. Here's What Investors Should Know

A director at Mettler-Toledo International Inc., Thomas P. Salice, sold 415 shares of common stock worth approximately $600,000 after exercising stock options. This transaction, occurring on August 3, was a same-day exercise and sale, where options acquired at a strike price of $397.95 were …

Mettler-Toledo's CFO Cashed In Options After a Strong Quarter. Here's What to Know

Mettler-Toledo International's CFO, Shawn Vadala, sold 2,240 shares for approximately $3.2 million on August 3, 2026, by exercising stock options. This transaction followed a strong quarter for the company, which reported significant revenue growth and raised its full-year outlook. Despite the sale, Vadala retains …

RadNet Inc (RDNT) (Q2 2026) Earnings Call Highlights: Record Revenue and AI-Driven Growth ...

This article first appeared on GuruFocus. Total Company Revenue: $622.7 million, up 25% from $498.2 million in Q2 2025. Total Company Adjusted EBITDA: $99.7 million, up 22.7% from $81.2 million in Q2 2025. Advanced Imaging Procedural Volumes: Aggregate volumes increased 21.2%; same-center volumes increased …

TWST shareholder (NASDAQ: TWST) files to sell 113,318 common shares

Emily M. Leproust, a shareholder of Twist Bioscience Corp (NASDAQ: TWST), has filed a Form 144 notice indicating her intent to sell 113,318 shares of common stock through Fidelity Brokerage Services LLC. The aggregate market value of this proposed sale is $14,183,056.89, with the …

Guardant Health grants 46,044 RSUs to 149 new employees under inducement plan

Guardant Health has granted 46,044 Restricted Stock Units (RSUs) to 149 new non-executive employees under its 2023 Employment Inducement Incentive Award Plan. The grants were made on August 3, 2026, and will vest in three equal annual installments, contingent on continued employment. This news …

Earnings call transcript: Insight Molecular Diagnostics posts mixed Q2 2026 results

* Insight Molecular Diagnostics Inc. (IMDX [https://seekingalpha.com/symbol/IMDX]) is scheduled to announce Q2 earnings results on Monday, August 10th, after market close. * The consensus EPS estimate is -$0.25, [https://seekingalpha.com/symbol/IMDX/earnings/estimates] and the consensus revenue estimate is $0.44M * Over the last year, IMDX has beaten …

A Natera Co-Founder Sold Into Record Highs. Here's What Long-Term Investors Should Know

Key Points The co-founder sold 9,150 shares for a total transaction value of approximately $2.9 million, based on the weighted-average execution price. The disposition reduced the insider's total equity holdings by 3% across direct and indirect accounts. Post-transaction ownership includes roughly 236,000 shares held …

Insight Molecular Diagnostics earnings beat, revenue fell short of estimates

Insight Molecular Diagnostics (NASDAQ: IMDX) reported second-quarter EPS of $-0.230, exceeding analyst estimates of $-0.240. However, the company's revenue of $240K fell short of the consensus estimate of $470.85K. Despite the revenue miss, the company's stock price has shown significant volatility, being down -25.700% …

Thermo Fisher Scientific (NYSE:TMO) CAO Joseph Holmes Sells 420 Shares

Thermo Fisher Scientific's Chief Accounting Officer, Joseph Holmes, sold 420 shares of company stock for a total of $245,620.20, reducing his direct ownership by 12.4%. Despite the insider sale, Thermo Fisher shares rose 0.8%, and the company exceeded analyst expectations for both quarterly EPS …

Victoria Creamer Sells 4,179 Shares of Charles River Laboratories International (NYSE:CRL) Stock

Victoria Creamer, EVP of Charles River Laboratories International (NYSE:CRL), sold 4,179 shares for over $1.08 million, reducing her holdings by 12.21%. Despite the insider sale, the company recently reported strong quarterly earnings, beating estimates with $3.02 EPS and $1 billion in revenue, and analysts …